Thiol redox barrier; local and systemic surveillance against stress and inflammatory diseases

• Published in: Archives of biochemistry and biophysics Vol. 595; pp. 88 - 93
• Main Authors: Yodoi, Junji, Tian, Hai, Masutani, Hiroshi, Nakamura, Hajime
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-04-2016
• Subjects: Animals; Anti-allergic action; Anti-inflammation; Development of drug; Humans; Inflammation - prevention & control; Inflammatory diseases; Oxidation-Reduction; Oxidative Stress; Redox regulation; Skin care and functional food; Stress; Thioredoxin; Thioredoxins - metabolism; Anti-allergic action; Redox regulation; Skin care and functional food; Development of drug; Thioredoxin; Inflammatory diseases; Stress; Anti-inflammation
• ISSN: 0003-9861; 1096-0384
• DOI: 10.1016/j.abb.2015.11.029

A 12-kDa protein with redox-active dithiol in the active site -Cys-Gly-Pro-Cys-, human thioredoxin 1 (TRX) has demonstrated an excellent anti-inflammatory effect in various animal models. TRX is induced by various oxidative stress factors, including ultraviolet rays, radiation, oxidation, viral infections, ischemia reperfusion and anticancer agents, and are involved in the pathogenesis and progression of various diseases. We have demonstrated that systemic administration and transgenic overexpression of TRX is effective in a wide variety of in vivo inflammatory disease models, such as viral pneumonia, acute lung injury, chronic obstructive pulmonary disease, indomethacin-induced gastric injury, and dermatitis. Our recent studies indicate that topically applied TRX prevents skin inflammation via the inhibition of local formation of inflammatory cytokines and chemokines. These indicate that the activation of inflammasome in skin and mucosa may be regulated by TRX. These suggest that application of TRX may be useful for the treatment of various skin and mucosal inflammatory disorders. Based on these results, we are conducting clinical studies to develop human recombinant thioredoxin 1 (rhTRX) pharmaceuticals. We have also developed substances that increase the expression of TRX in the body (TRX-inducing substances) in vegetables and other plant ingredients, and we are also developing skin-care products and functional foods that take advantage of the anti-inflammation and anti-allergic action of TRX.